Murphy Lam Yim Wan

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Escherichia Coli

Cell Cycle Arrest

Systemic Sclerosis

Top Venues

Pathogens (Basel, Switzerland)

ACS pharmacology & translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Vanessa Anna Co, Hani El-Nezami, Yawen Liu, Bonsra Twum, Priyanka Dey, Paul A Cox, Shalu Joseph, Roland Agbodjan-Dossou, Mehdi Sabzichi, Roger R Draheim, Murphy Lam Yim Wan
Schisandrin B Suppresses Colon Cancer Growth by Inducing Cell Cycle Arrest and Apoptosis: Molecular Mechanism and Therapeutic Potential. ACS pharmacology & translational science 7 (3) (2024)
Vanessa Anna Co, Hani El-Nezami, Yawen Liu, Bonsra Twum, Priyanka Dey, Paul A Cox, Shalu Joseph, Roland Agbodjan-Dossou, Mehdi Sabzichi, Roger R Draheim, Murphy Lam Yim Wan
Schisandrin B Suppresses Colon Cancer Growth by Inducing Cell Cycle Arrest and Apoptosis: Molecular Mechanism and Therapeutic Potential. ACS pharmacology & translational science 7 (3) (2024)
Murphy Lam Yim Wan, Thi Hien Tran, Daniel S C Butler, Michele Cavalera, Murphy Lam Yim Wan, Shahram Ahmadi, Catharina Svanborg
Therapeutic Effects of IL-1RA against Acute Bacterial Infections, including Antibiotic-Resistant Strains. Pathogens (Basel, Switzerland) 13 (1) (2023)
Murphy Lam Yim Wan, Thi Hien Tran, Daniel S C Butler, Michele Cavalera, Murphy Lam Yim Wan, Shahram Ahmadi, Catharina Svanborg
Therapeutic Effects of IL-1RA against Acute Bacterial Infections, including Antibiotic-Resistant Strains. Pathogens (Basel, Switzerland) 13 (1) (2023)
Murphy Lam Yim Wan, Thi Hien Tran, Daniel S C Butler, Michele Cavalera, Murphy Lam Yim Wan, Shahram Ahmadi, Catharina Svanborg
Therapeutic Effects of IL-1RA against Acute Bacterial Infections, including Antibiotic-Resistant Strains. Pathogens (Basel, Switzerland) 13 (1) (2023)